Faculty and fellows in the Medical Toxicology section have multiple active research projects, with a particular focus on Addiction Medicine, Global Health, and human health effects of radiation. Fellows have also participated in write-ups related to public health deployments during the CDC portion of the fellowship. Faculty have received external research funding from multiple NIH institutes, as well as internal grant funding from the Emory Medical Care Foundation. In addition to fellows, trainees of all levels, including medical students, residents, and pharmacists, also commonly participate in our research projects.
Recently, we were selected as a site for the ED-INNOVATION study, a multisite NIH-funded randomized clinical trial assessing the efficacy of extended-release buprenorphine in emergency department patients.
Current and former fellows have presented their work at national conferences including:
- North American Congress of Clinical Toxicology
- American College of Medical Toxicology Annual Scientific Meeting
- American Society of Addiction Medicine
- American College of Emergency Physicians
Our work has been published in Medical Toxicology journals including Clinical Toxicology and Journal of Medical Toxicology, as well as more widely circulated journals such as American Journal of Public Health, Chest, and Morbidity and Mortality Weekly Report (MMWR).
Selected recent publications:
Addiction Medicine
Global Health
EVALI Outbreak
Epidemiology and Public Health
E-cigarette Vaping Associated Lung Injury Outbreak in 2019-20
Below are several of the papers that the Emory Emergency Medicine Toxicology fellows authored or co-authored in response to the e-cigarette vaping associated lung injury outbreak in 2019-20.
Kiernan E, Click ES, Melstrom P, Click ES, et al. A brief overview of the national outbreak of e-cigarette, or vaping, product use-associated lung injury and the primary causes. Chest 159 (1):426--31. 2020
Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, Navon L, Hoots B, Salvatore PP, Elderbrook M, et al. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med 382(10):903-916 05 Mar 2020 (Journal article)
Jatlaoui TC, Wiltz JL, Kabbani S, et al. Update: Interim Guidance for Health Care Providers For Managing Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, November 2019. MMWR Morb Mortal Wkly Rep 2019; 68(46): 1081-1086
Chatham-Stephens K, Roguski K, Jang Y et al. Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury – United States, November 2019. MMWR Morb Mortal Wkly Rep 2019; 68(46): 1076-1080
Moritz ED, Zapata LB, Lekiachvili et al. Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries – Unites States, October 2019. MMWR Morb Mortal Wkly Rep 2019; 68(43): 985-989
Siegel DA, Jatlaoui TC, Koumans EH, et al. Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019. MMWR Morb Mortal Wkly Rep 2019; 68(41):919–927
Ghinai I, Pray IW, Navon L, et al. E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury – Illinois and Wisconsin, April – September 2019. MMWR Morb Mortal Wkly Rep 2019; 68(39): 865-869
Schier JH, Meiman JH, Layden J, et al. Severe pulmonary disease associated with electronic-cigrarette-product use – interim guidance. MMWR Morb Mortal Wkly Rep 2019; 68(36): 787-790